Share price at the NSE close on 23 Oct 2026. Previous close ₹70.05.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,026 Cr1,241st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 15 Jul 2026
- 7.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 0.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 15 Jul 2026
- 11.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 15 Jul 2026
- 15.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 9,25,78245.7% delivered
Sai Silks (Kalamandir) board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonRavindra Vikram Mamidipudi
- Company Secretary and Compliance OfficerShilpa Kotagiri
7 directors4 independent3 executive
- Ravindra Vikram Mamidipudi · ChairpersonIndependent · joined Feb 2022 · reappointed Feb 2022 · 54 months as independent · 3 listed boards · 2 as independent · 2 committee seats, 2 as chair
- Nagakanaka Durga Prasad ChalavadiExecutive · joined Jul 2008 · reappointed Jul 2023 · 1 listed board
- Kalyan Srinivas AnnamExecutive · joined Apr 2009 · reappointed Jul 2023 · 1 listed board
- Doodeswara KanakaDurgarao ChalavadiExecutive · joined Jun 2009 · reappointed Jul 2023 · 1 listed board
- Pramod KasatIndependent · joined Feb 2022 · reappointed Feb 2022 · 54 months as independent · 0 listed boards · 5 as independent · 7 committee seats, 3 as chair
- Kunisetty VenkataRamakrishnaIndependent · joined Jun 2022 · reappointed Jun 2022 · 51 months as independent · 1 listed board · 1 as independent · 1 committee seat
- Sridevi DasariIndependent · joined May 2026 · reappointed May 2026 · 4 months as independent · 0 listed boards · 2 as independent · 3 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- Sirisha Chintapalli, left 6 May 2026: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 29 Sep 20267 of 7 present4 independent · 75 days in between
- 15 Jul 20266 of 7 present4 independent · 8 days in between
- 6 Jul 20266 of 7 present4 independent
Audit Committee
Chair Ravindra Vikram Mamidipudi
Pramod Kasat, Kunisetty VenkataRamakrishna, Sridevi Dasari
- 29 Sep 20264 of 4 present4 independent · 75 days in between
- 15 Jul 20264 of 4 present4 independent
Nomination and remuneration committee
Chair Kunisetty VenkataRamakrishna
Ravindra Vikram Mamidipudi, Pramod Kasat, Sridevi Dasari
- 29 Sep 20264 of 4 present4 independent · 75 days in between
- 15 Jul 20264 of 4 present4 independent
Stakeholders Relationship Committee
Chair Sridevi Dasari
Nagakanaka Durga Prasad Chalavadi, Kalyan Srinivas Annam
No meeting listed in the filing.
Risk Management Committee
Chair Nagakanaka Durga Prasad Chalavadi
Kalyan Srinivas Annam, Doodeswara KanakaDurgarao Chalavadi, Ravindra Vikram Mamidipudi, Venkata Lakshmi Narasimha Sarma Konduri
- 14 Aug 20264 of 4 present1 independent
Corporate Social Responsibility Committee
Chair Ravindra Vikram Mamidipudi
Nagakanaka Durga Prasad Chalavadi, Kalyan Srinivas Annam
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Sagar & AssociatesPeer-review certificate valid to Nov 2028
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Sai Silks (Kalamandir) AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Sai Silks (Kalamandir) dividend history
Annual general meeting, 10 Aug 2026
66,778 shareholders on the register on 3 Aug 2026; present: 2 promoters and 89 others; votes counted by VIKAS SIROHIYA / P S RAO & ASSOCIATES.The company's voting result (opens in a new tab)
To receive, consider, and adopt the Audited Financial Statement of the Company for the financial year ended March 31, 2026 along with the Notes thereon and the Reports of the Board of Directors and the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.50%
Turnout: all 65.16% · promoters 100.00% · institutions 84.27% · other public 0.41%
- To declare final dividend @ Rs1.50/- per Equity Share of Rs. 2/- each for the Financial Year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.48%
Turnout: all 65.16% · promoters 100.00% · institutions 84.27% · other public 0.41%
- To appoint a director in place of Mr. Doodeswara Kanaka Durgarao Chalavadi (DIN: 02689280) who retires by rotation and being eligible offers himself for reappointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.01%
Turnout: all 65.16% · promoters 100.00% · institutions 84.27% · other public 0.41%
- Reappointment of Statutory Auditors of the Company.Ordinary99.96% for0.04% against
Against: promoters 0.00% · institutions 0.00% · other public 16.73%
Turnout: all 65.16% · promoters 100.00% · institutions 84.27% · other public 0.41%
- Appointment of Mr. Bharadwaj Rachamadugu as Chief Executive Officer (CEO) of the CompanyOrdinaryPromoters have an interest in it95.22% for4.78% against
Against: promoters 0.00% · institutions 35.12% · other public 2.77%
Turnout: all 29.91% · promoters 42.17% · institutions 84.27% · other public 0.41%
- Appointment of Ms. Sridevi Dasari (DIN: 07512095) as an Independent Director of the company.Special99.96% for0.04% against
Against: promoters 0.00% · institutions 0.00% · other public 16.81%
Turnout: all 65.16% · promoters 100.00% · institutions 84.27% · other public 0.41%
- Payment of commission to Non-Executive Independent DirectorsOrdinary97.74% for2.26% against
Against: promoters 0.00% · institutions 35.63% · other public 17.76%
Turnout: all 65.16% · promoters 100.00% · institutions 84.27% · other public 0.41%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Aug 2025, 4 resolutions
57,128 shareholders on the register on 22 Aug 2025; present: 2 promoters and 72 others; votes counted by VIKAS SIROHIYA / P S RAO & ASSOCIATES.The company's voting result (opens in a new tab)
- Adoption of Audited Financial Statement of the Company for the financial year ended March 31, 2025 along with the Notes thereon and the Reports of the Board of Directors and the Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.56%
Turnout: all 74.20% · promoters 100.00% · institutions 84.00% · other public 0.18%
- Declaration of final dividend Rs.1.00/- per Equity Share of Rs. 2/- each for the Financial Year ended March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.26%
Turnout: all 74.20% · promoters 100.00% · institutions 84.00% · other public 0.18%
- Appointment of Mr. Kalyan Srinivas Annam (DIN: 02428313) to the office of Director, retirement by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.67%
Turnout: all 74.20% · promoters 100.00% · institutions 84.00% · other public 0.18%
- Appointment of PS Rao & Associates as Secretarial AuditorsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.53%
Turnout: all 74.20% · promoters 100.00% · institutions 84.00% · other public 0.18%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 27 Sep 2024, 3 resolutions
Present: 4 promoters and 44 others.The company's voting result (opens in a new tab)
To receive, consider, and adopt the Audited Financial Statement of the Company for the financial year ended 31st March, 2024 along with the Notes thereon and the Reports of the Board of Directors and the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.93%
Turnout: all 78.19% · promoters 100.00% · institutions 87.68% · other public 0.17%
- To declare final dividend @ Re.1.00/- per Equity Share of Rs 2/- each for the Financial Year ended March 31, 2024.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.93%
Turnout: all 78.19% · promoters 100.00% · institutions 87.68% · other public 0.17%
- To appoint a director in place of Mr. Doodeswara Kanaka Durgarao Chalavadi (DIN: 02689280) who retires by rotation and beingneligible offers himself for reappointment.Ordinary98.44% for1.56% against
Against: promoters 0.00% · institutions 6.67% · other public 2.63%
Turnout: all 75.98% · promoters 93.80% · institutions 87.68% · other public 0.20%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 10 Aug 2026, 2 fund houses so far (houses' deadline to file 15 Oct 2026)
To receive, consider, and adopt the Audited Financial Statement of the Company for the financial year ended March 31, 2026 along with the Notes thereon and the Reports of the Board of Directors and the Auditors thereon.MoreLess
2 for0 against- To declare final dividend @ Rs1.50/- per Equity Share of Rs. 2/- each for the Financial Year ended March 31, 2026.2 for0 against
- To appoint a director in place of Mr. Doodeswara Kanaka Durgarao Chalavadi (DIN: 02689280) who retires by rotation and being eligible offers himself for reappointment.2 for0 against
- Reappointment of Statutory Auditors of the Company.2 for0 against
- Appointment of Mr. Bharadwaj Rachamadugu as Chief Executive Officer (CEO) of the Company2 for0 against
- Appointment of Ms. Sridevi Dasari (DIN: 07512095) as an Independent Director of the company.2 for0 against
- Payment of commission to Non-Executive Independent Directors2 for0 against
Mutual fund votes, meeting of 29 Aug 2025, 6 fund houses
- Adoption of Audited Financial Statement of the Company for the financial year ended March 31, 2025 along with the Notes thereon and the Reports of the Board of Directors and the Auditors thereon.6 for0 against
- Declaration of final dividend Rs.1.00/- per Equity Share of Rs. 2/- each for the Financial Year ended March 31, 2025.6 for0 against
- Appointment of Mr. Kalyan Srinivas Annam (DIN: 02428313) to the office of Director, retirement by rotation
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with law. Governance Concern: Remuneration practice appears to be disjointed & skewed among the Promoter Directors.
5 for1 against - Appointment of PS Rao & Associates as Secretarial Auditors6 for0 against
1 earlier meeting
Mutual fund votes, meeting of 27 Sep 2024, 10 fund houses
To receive, consider, and adopt the Audited Financial Statement of the Company for the financial year ended 31st March, 2024 along with the Notes thereon and the Reports of the Board of Directors and the Auditors thereon.MoreLess
9 for0 against- To declare final dividend @ Re.1.00/- per Equity Share of Rs 2/- each for the Financial Year ended March 31, 2024.9 for0 against
- To appoint a director in place of Mr. Doodeswara Kanaka Durgarao Chalavadi (DIN: 02689280) who retires by rotation and beingneligible offers himself for reappointment.10 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Tax disputes
Reported in the filing for the quarter to Sep 2026.
- Tax disputeDeputy Commissioner of Income Tax, Central circle 1(3), HyderabadSince 27 Dec 2018No further response from the departmentAt the filing before: Contingent Liabilities for the AY 2016-17 - Rs. 0.89 Cr Company has filed a rectification request u/s 154 of the Income Tax act 1961
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere | Spent elsewhere, amount | Reason and comments |
|---|---|---|---|---|---|---|---|
| Public IssuesSep 2023, checked by CARE RATINGS LIMITED | 600.00 | Funding capital expenditure towards setting-up of 30 new stores (“New Stores”); | 122.72 | 116.23 | No | 2.36 | The net proceeds of the issue are Rs.566.24 crore out of which Rs.539.47 crore was spent as of June 30, 2026. There has been a deviation in the timelines for utilization of funds under Objects 1 and 2; however, the necessary approval from the Board of Directors for extension of the timelines has been obtained. Further, an amount of Rs.2.36 crore has been utilized towards Object 3, i.e., “Funding working capital requirements of the company,” from the funds originally earmarked for Object 1, i.e., “Funding capital expenditure for setting up of 30 new stores.” The Board of Directors has approved the said reallocation. There are no material deviations in the utilization of proceeds. However, there is a deviation in the amount spent towards Object 3 as compared to the earmarked funds as per the IPO document. The deviation is within 10% as of June 30, 2026, and the necessary approval from the Board of Directors has been obtained. The means of finance for Objects 1 and 3 have been revised; however, the overall proceeds allocated towards the objects specified in the IPO document remain unchanged. The revision in funding towards objects 1 & 3 was already considered at the time of issuance of earlier monitoring report for Q4FY26.MoreLess |
| Public IssuesSep 2023, checked by CARE RATINGS LIMITED | 600.00 | Funding capital expenditure towards setting-up of two warehouses; | 25.40 | 5.12 | No | The net proceeds of the issue are Rs.566.24 crore out of which Rs.539.47 crore was spent as of June 30, 2026. There has been a deviation in the timelines for utilization of funds under Objects 1 and 2; however, the necessary approval from the Board of Directors for extension of the timelines has been obtained. Further, an amount of Rs.2.36 crore has been utilized towards Object 3, i.e., “Funding working capital requirements of the company,” from the funds originally earmarked for Object 1, i.e., “Funding capital expenditure for setting up of 30 new stores.” The Board of Directors has approved the said reallocation. There are no material deviations in the utilization of proceeds. However, there is a deviation in the amount spent towards Object 3 as compared to the earmarked funds as per the IPO document. The deviation is within 10% as of June 30, 2026, and the necessary approval from the Board of Directors has been obtained. The means of finance for Objects 1 and 3 have been revised; however, the overall proceeds allocated towards the objects specified in the IPO document remain unchanged. The revision in funding towards objects 1 & 3 was already considered at the time of issuance of earlier monitoring report for Q4FY26.MoreLess | |
| Public IssuesSep 2023, checked by CARE RATINGS LIMITED | 600.00 | Funding working capital requirements of our Company; | 282.43 | 282.43 | No | 2.36 | The net proceeds of the issue are Rs.566.24 crore out of which Rs.539.47 crore was spent as of June 30, 2026. There has been a deviation in the timelines for utilization of funds under Objects 1 and 2; however, the necessary approval from the Board of Directors for extension of the timelines has been obtained. Further, an amount of Rs.2.36 crore has been utilized towards Object 3, i.e., “Funding working capital requirements of the company,” from the funds originally earmarked for Object 1, i.e., “Funding capital expenditure for setting up of 30 new stores.” The Board of Directors has approved the said reallocation. There are no material deviations in the utilization of proceeds. However, there is a deviation in the amount spent towards Object 3 as compared to the earmarked funds as per the IPO document. The deviation is within 10% as of June 30, 2026, and the necessary approval from the Board of Directors has been obtained. The means of finance for Objects 1 and 3 have been revised; however, the overall proceeds allocated towards the objects specified in the IPO document remain unchanged. The revision in funding towards objects 1 & 3 was already considered at the time of issuance of earlier monitoring report for Q4FY26.MoreLess |
| Public IssuesSep 2023, checked by CARE RATINGS LIMITED | 600.00 | Repayment or pre-payment, in full or part, of certain borrowings availed by our Company; and | 50.00 | 50.00 | No | The net proceeds of the issue are Rs.566.24 crore out of which Rs.539.47 crore was spent as of June 30, 2026. There has been a deviation in the timelines for utilization of funds under Objects 1 and 2; however, the necessary approval from the Board of Directors for extension of the timelines has been obtained. Further, an amount of Rs.2.36 crore has been utilized towards Object 3, i.e., “Funding working capital requirements of the company,” from the funds originally earmarked for Object 1, i.e., “Funding capital expenditure for setting up of 30 new stores.” The Board of Directors has approved the said reallocation. There are no material deviations in the utilization of proceeds. However, there is a deviation in the amount spent towards Object 3 as compared to the earmarked funds as per the IPO document. The deviation is within 10% as of June 30, 2026, and the necessary approval from the Board of Directors has been obtained. The means of finance for Objects 1 and 3 have been revised; however, the overall proceeds allocated towards the objects specified in the IPO document remain unchanged. The revision in funding towards objects 1 & 3 was already considered at the time of issuance of earlier monitoring report for Q4FY26.MoreLess | |
| Public IssuesSep 2023, checked by CARE RATINGS LIMITED | 600.00 | General corporate purposes. | 85.69 | 85.69 | No | The net proceeds of the issue are Rs.566.24 crore out of which Rs.539.47 crore was spent as of June 30, 2026. There has been a deviation in the timelines for utilization of funds under Objects 1 and 2; however, the necessary approval from the Board of Directors for extension of the timelines has been obtained. Further, an amount of Rs.2.36 crore has been utilized towards Object 3, i.e., “Funding working capital requirements of the company,” from the funds originally earmarked for Object 1, i.e., “Funding capital expenditure for setting up of 30 new stores.” The Board of Directors has approved the said reallocation. There are no material deviations in the utilization of proceeds. However, there is a deviation in the amount spent towards Object 3 as compared to the earmarked funds as per the IPO document. The deviation is within 10% as of June 30, 2026, and the necessary approval from the Board of Directors has been obtained. The means of finance for Objects 1 and 3 have been revised; however, the overall proceeds allocated towards the objects specified in the IPO document remain unchanged. The revision in funding towards objects 1 & 3 was already considered at the time of issuance of earlier monitoring report for Q4FY26.MoreLess |